Therefore, Nix could be an alternative mediator of mitophagy and could serve as a neuroprotective therapy in PD due to PINK1 or PRKN mutations (Koentjoro et al., 2017; Naeem et al., 2020). The gene discussed is PRKN; the disease is Parkinson disease.